184 related articles for article (PubMed ID: 22403631)
1. Epidermal growth factor gene polymorphism and risk of hepatocellular carcinoma: a meta-analysis.
Zhong JH; You XM; Gong WF; Ma L; Zhang Y; Mo QG; Wu LC; Xiao J; Li LQ
PLoS One; 2012; 7(3):e32159. PubMed ID: 22403631
[TBL] [Abstract][Full Text] [Related]
2. Association between epidermal growth factor gene +61A/G polymorphism and the risk of hepatocellular carcinoma: a meta-analysis based on 16 studies.
Jiang G; Yu K; Shao L; Yu X; Hu C; Qian P; Xie H; Li J; Zheng J; Zheng S
BMC Cancer; 2015 Apr; 15():314. PubMed ID: 25927412
[TBL] [Abstract][Full Text] [Related]
3. Meta-analysis of microsomal epoxide hydrolase gene polymorphism and risk of hepatocellular carcinoma.
Zhong JH; Xiang BD; Ma L; You XM; Li LQ; Xie GS
PLoS One; 2013; 8(2):e57064. PubMed ID: 23451147
[TBL] [Abstract][Full Text] [Related]
4. Association between the epidermal growth factor 61*A/G polymorphism and hepatocellular carcinoma risk: a meta-analysis.
Sun S; Jin GJ; Zhao Y; Kang H
Asian Pac J Cancer Prev; 2015; 16(7):3009-14. PubMed ID: 25854398
[TBL] [Abstract][Full Text] [Related]
5. Epidermal growth factor 61A>G polymorphism is associated with risk of hepatocellular carcinoma: a meta-analysis.
Yang Z; Wu Q; Shi Y; Nie Y; Wu K; Fan D
Genet Test Mol Biomarkers; 2012 Sep; 16(9):1086-91. PubMed ID: 22852842
[TBL] [Abstract][Full Text] [Related]
6. Association between the EGF rs4444903 polymorphism and liver cancer susceptibility: a meta-analysis and meta-regression.
Li YL; Tian Z; Zhao L; Zhang CL
Genet Mol Res; 2014 Oct; 13(4):8066-79. PubMed ID: 25299191
[TBL] [Abstract][Full Text] [Related]
7. Genetic polymorphisms of epidermal growth factor in relation to risk of hepatocellular carcinoma: two case-control studies.
Yuan JM; Fan Y; Ognjanovic S; Wang R; Van Den Berg D; Govindarajan S; Yu MC
BMC Gastroenterol; 2013 Feb; 13():32. PubMed ID: 23419149
[TBL] [Abstract][Full Text] [Related]
8. Association between epidermal growth factor gene rs4444903 polymorphism and risk of glioma.
Hu M; Shi H; Xu Z; Liu W
Tumour Biol; 2013 Jun; 34(3):1879-85. PubMed ID: 23645212
[TBL] [Abstract][Full Text] [Related]
9. Epidermal growth factor +61 G/A polymorphism and the risk of hepatocellular carcinoma in a Chinese population.
Chen K; Wei Y; Yang H; Li B
Genet Test Mol Biomarkers; 2011 Apr; 15(4):251-5. PubMed ID: 21186997
[TBL] [Abstract][Full Text] [Related]
10. EGF rs4444903 polymorphism is associated with risk of HCV-related cirrhosis and HBV/HCV-related hepatocellular carcinoma.
Wang J; Zhong Y; Meng G
Int J Clin Oncol; 2021 Nov; 26(11):2053-2064. PubMed ID: 34291370
[TBL] [Abstract][Full Text] [Related]
11. Association between rs738409 polymorphism in patatin-like phospholipase domain-containing protein 3 (PNPLA3) gene and hepatocellular carcinoma susceptibility: Evidence from case-control studies.
Li JF; Zheng EQ; Xie M
Gene; 2019 Feb; 685():143-148. PubMed ID: 30403964
[TBL] [Abstract][Full Text] [Related]
12. X-ray repair cross-complementing group 1 polymorphisms and hepatocellular carcinoma: a meta-analysis.
Xie T; Wang ZG; Zhang JL; Liu H
World J Gastroenterol; 2012 Aug; 18(31):4207-14. PubMed ID: 22919255
[TBL] [Abstract][Full Text] [Related]
13. Epidermal growth factor gene functional polymorphism and the risk of hepatocellular carcinoma in patients with cirrhosis.
Tanabe KK; Lemoine A; Finkelstein DM; Kawasaki H; Fujii T; Chung RT; Lauwers GY; Kulu Y; Muzikansky A; Kuruppu D; Lanuti M; Goodwin JM; Azoulay D; Fuchs BC
JAMA; 2008 Jan; 299(1):53-60. PubMed ID: 18167406
[TBL] [Abstract][Full Text] [Related]
14. XRCC1 genetic polymorphism Arg399Gln and hepatocellular carcinoma risk: a meta-analysis.
Liu F; Li B; Wei Y; Yan L; Wen T; Zhao J; Xu M
Liver Int; 2011 Jul; 31(6):802-9. PubMed ID: 21645210
[TBL] [Abstract][Full Text] [Related]
15. No association of EGF 5'UTR variant A61G and hepatocellular carcinoma in Chinese patients with chronic hepatitis B virus infection.
Qi P; Wang H; Chen YM; Sun XJ; Liu Y; Gao CF
Pathology; 2009; 41(6):555-60. PubMed ID: 19900104
[TBL] [Abstract][Full Text] [Related]
16. Association of interleukin-6 gene polymorphisms with the risk of hepatocellular carcinoma: An up-to-date meta-analysis.
An PP; Feng LN; Zhang XX; Jin QL
Medicine (Baltimore); 2020 Dec; 99(50):e23659. PubMed ID: 33327352
[TBL] [Abstract][Full Text] [Related]
17. A functional polymorphism in the epidermal growth factor gene is associated with risk for hepatocellular carcinoma.
Abu Dayyeh BK; Yang M; Fuchs BC; Karl DL; Yamada S; Sninsky JJ; O'Brien TR; Dienstag JL; Tanabe KK; Chung RT;
Gastroenterology; 2011 Jul; 141(1):141-9. PubMed ID: 21440548
[TBL] [Abstract][Full Text] [Related]
18. The XRCC1 Arg399Gln genetic polymorphism contributes to hepatocellular carcinoma susceptibility: an updated meta-analysis.
Pan Y; Zhao L; Chen XM; Gu Y; Shen JG; Liu LM
Asian Pac J Cancer Prev; 2013; 14(10):5761-7. PubMed ID: 24289575
[TBL] [Abstract][Full Text] [Related]
19. Lack of association of EPHX1 gene polymorphisms with risk of hepatocellular carcinoma: a meta-analysis.
Duan CY; Liu MY; Li SB; Ma KS; Bie P
Tumour Biol; 2014 Jan; 35(1):659-66. PubMed ID: 23955801
[TBL] [Abstract][Full Text] [Related]
20. Association between the risk of hepatitis virus-related hepatocellular carcinoma and EGF polymorphism: A PRISMA-compliant updated meta-analysis.
Wang Q; Xu L; Wu Q; Zhang M; Zhang J
Medicine (Baltimore); 2022 Oct; 101(42):e31280. PubMed ID: 36281156
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
